Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24
Introduction Influenza A(H1N1)pdm09, A(H3N2) and B/Victoria viruses circulated in Europe in 2023/24, with A(H1N1)pdm09 dominance. First influenza infections in childhood may lead to different vaccine effectiveness (VE) in subsequent years. Aim The VEBIS primary care network estimated influenza VE in...
Saved in:
| Main Author: | on behalf of the European primary care VE group |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Centre for Disease Prevention and Control
2025-06-01
|
| Series: | Eurosurveillance |
| Subjects: | |
| Online Access: | https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.23.2500011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity of Modern Vaccine Viruses of Influenza A (H1N1)pdm09 According to Graphical Analysis
by: V. S. Vakin, et al.
Published: (2017-10-01) -
Early and Late Influenza Vaccine Effectiveness in South Korea During the 2023–2024 Season
by: Yu Jung Choi, et al.
Published: (2025-02-01) -
A preliminary exploration of influenza-like illness surveillance and influenza vaccination in Jing’an District of Shanghai, 2017‒2023
by: HUA Ruijue, et al.
Published: (2025-04-01) -
Influence of perceived influenza-like symptoms on intention to receive seasonal influenza vaccination
by: Renske Eilers, et al.
Published: (2025-03-01) -
Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024
by: Emi Takashita, et al.
Published: (2025-05-01)